These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 30115393)

  • 1. Proteoform Analysis to Fulfill Unmet Clinical Needs and Reach Global Standardization of Protein Measurands in Clinical Chemistry Proteomics.
    van der Burgt YEM; Cobbaert CM
    Clin Lab Med; 2018 Sep; 38(3):487-497. PubMed ID: 30115393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elucidating Proteoform Families from Proteoform Intact-Mass and Lysine-Count Measurements.
    Shortreed MR; Frey BL; Scalf M; Knoener RA; Cesnik AJ; Smith LM
    J Proteome Res; 2016 Apr; 15(4):1213-21. PubMed ID: 26941048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ICPL--isotope-coded protein label.
    Kellermann J
    Methods Mol Biol; 2008; 424():113-23. PubMed ID: 18369857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expanding Proteoform Identifications in Top-Down Proteomic Analyses by Constructing Proteoform Families.
    Schaffer LV; Shortreed MR; Cesnik AJ; Frey BL; Solntsev SK; Scalf M; Smith LM
    Anal Chem; 2018 Jan; 90(2):1325-1333. PubMed ID: 29227670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PSAQ™ standards for accurate MS-based quantification of proteins: from the concept to biomedical applications.
    Picard G; Lebert D; Louwagie M; Adrait A; Huillet C; Vandenesch F; Bruley C; Garin J; Jaquinod M; Brun V
    J Mass Spectrom; 2012 Oct; 47(10):1353-63. PubMed ID: 23019168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current trends in quantitative proteomics - an update.
    Li H; Han J; Pan J; Liu T; Parker CE; Borchers CH
    J Mass Spectrom; 2017 May; 52(5):319-341. PubMed ID: 28418607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mass spectrometry-based proteomics: current status and potential use in clinical chemistry.
    Binz PA; Hochstrasser DF; Appel RD
    Clin Chem Lab Med; 2003 Dec; 41(12):1540-51. PubMed ID: 14708878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective applications of ultrahigh resolution proteomics in clinical mass spectrometry.
    Ruhaak LR; van der Burgt YE; Cobbaert CM
    Expert Rev Proteomics; 2016 Dec; 13(12):1063-1071. PubMed ID: 27798968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of Proteoforms with Unknown Post-translational Modifications Using the MIScore.
    Kou Q; Zhu B; Wu S; Ansong C; Tolić N; Paša-Tolić L; Liu X
    J Proteome Res; 2016 Aug; 15(8):2422-32. PubMed ID: 27291504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteoforms and Proteoform Families: Past, Present, and Future.
    Smith LM
    Methods Mol Biol; 2022; 2500():1-4. PubMed ID: 35657582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Top-Down Mass Spectrometry: Proteomics to Proteoforms.
    Patrie SM
    Adv Exp Med Biol; 2016; 919():171-200. PubMed ID: 27975217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mass spectrometry-based targeted quantitative proteomics: achieving sensitive and reproducible detection of proteins.
    Boja ES; Rodriguez H
    Proteomics; 2012 Apr; 12(8):1093-110. PubMed ID: 22577011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advancing Top-down Analysis of the Human Proteome Using a Benchtop Quadrupole-Orbitrap Mass Spectrometer.
    Fornelli L; Durbin KR; Fellers RT; Early BP; Greer JB; LeDuc RD; Compton PD; Kelleher NL
    J Proteome Res; 2017 Feb; 16(2):609-618. PubMed ID: 28152595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteoform Suite: Software for Constructing, Quantifying, and Visualizing Proteoform Families.
    Cesnik AJ; Shortreed MR; Schaffer LV; Knoener RA; Frey BL; Scalf M; Solntsev SK; Dai Y; Gasch AP; Smith LM
    J Proteome Res; 2018 Jan; 17(1):568-578. PubMed ID: 29195273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulatory considerations for clinical mass spectrometry: multiple reaction monitoring.
    Boja ES; Rodriguez H
    Clin Lab Med; 2011 Sep; 31(3):443-53. PubMed ID: 21907108
    [No Abstract]   [Full Text] [Related]  

  • 16. Protocol for Standardizing High-to-Moderate Abundance Protein Biomarker Assessments Through an MRM-with-Standard-Peptides Quantitative Approach.
    Percy AJ; Yang J; Chambers AG; Mohammed Y; Miliotis T; Borchers CH
    Adv Exp Med Biol; 2016; 919():515-530. PubMed ID: 27975233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The analysis of native proteins and peptides in the clinical lab using mass spectrometry.
    Bystrom CE
    Clin Lab Med; 2011 Sep; 31(3):397-405. PubMed ID: 21907105
    [No Abstract]   [Full Text] [Related]  

  • 18. Quantitative mass spectrometry in proteomics: a critical review.
    Bantscheff M; Schirle M; Sweetman G; Rick J; Kuster B
    Anal Bioanal Chem; 2007 Oct; 389(4):1017-31. PubMed ID: 17668192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Towards an SI-Traceable Reference Measurement System for Seven Serum Apolipoproteins Using Bottom-Up Quantitative Proteomics: Conceptual Approach Enabled by Cross-Disciplinary/Cross-Sector Collaboration.
    Cobbaert CM; Althaus H; Begcevic Brkovic I; Ceglarek U; Coassin S; Delatour V; Deprez L; Dikaios I; Dittrich J; Hoofnagle AN; Kostner GM; Kronenberg F; Kuklenyik Z; Prinzing U; Vesper HW; Zegers I; Ruhaak LR;
    Clin Chem; 2021 Mar; 67(3):478-489. PubMed ID: 33331636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evolution of Myeloma Testing in Clinical Chemistry with Mass Spectrometry.
    Murray DL; Willrich MAV
    J Appl Lab Med; 2019 Nov; 4(3):474-476. PubMed ID: 31659091
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.